General Announcement::DRUG DEVELOPMENT UPDATES FOR WAFERMINE AND WAFESIL
Issuer & Securities
Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
19-Jul-2022 07:28:35
Status
New
Announcement Sub Title
DRUG DEVELOPMENT UPDATES FOR WAFERMINE AND WAFESIL
Announcement Reference
SG220719OTHRPGKH
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please see attached.
Attachments
Press Release - Wafermine and Wafesil Update.pdf
Total size =258K
Related Announcements
Related Announcements